Semaglutide, a key ingredient of weight-loss drugs like Wegovy and Ozempic, has been found to slow down ageing and curb the causes of many chronic diseases.
Used to cut body inflammation, semaglutide could also treat multiple diseases related to inflammation such as cancer, arthritis, Alzheimer’s, and Parkinson’s.
Semaglutide is revolutionizing healthcare beyond just weight loss. It represents a significant leap in medical science, offering hope for millions, addressing obesity and its related comorbidities, and potentially reshaping our approach to preventive care. It may herald a new era in healthcare, tackling multiple health concerns with a single, powerful tool.
Semaglutide-based medication is now being used indiscriminately for weight loss, often without proper medical supervision. This raises concerns about potential side effects, including nausea, gallbladder issues, and even kidney damage. Long-term health consequences remain unknown.